Clinical Trials Logo

Clinical Trial Summary

Kidney transplantation (KT) failure could be due to surgery dependent factors and particularly surgeon's experience. Objective: To assess the impact of the surgeon's experience on the post-operative outcomes to know if it safe for young surgeons to perform it.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05200949
Study type Observational
Source Centre Hospitalier Universitaire de Nice
Contact
Status Completed
Phase
Start date January 1, 2013
Completion date December 31, 2015

See also
  Status Clinical Trial Phase
Withdrawn NCT04216303 - Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
Recruiting NCT03689075 - Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation Phase 4
Recruiting NCT03870542 - Multicenter, Prospective Study for Urinary Exosomal Biomarkers of Kidney Allograft Tubulointerstitial Fibrosis
Not yet recruiting NCT04560582 - Immunosuppression Reduction in Failed Allograft Guided by cfDNA
Recruiting NCT04882254 - Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes? Phase 2
Recruiting NCT04918199 - Human Versus Computer-based Predictions of Long Allograft Survival
Recruiting NCT04897438 - Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection N/A
Recruiting NCT04226859 - Trajectories of Glomerular Filtration Rate and Progression to End Stage Renal Disease After Kidney Transplantation
Active, not recruiting NCT02960802 - Kidney Transplantation and Renal and Myocardial Perfusion N/A
Completed NCT04258891 - Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation
Recruiting NCT04154267 - Protocol Biopsies in High-risk Renal Transplant Recipients N/A
Not yet recruiting NCT05285878 - Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation Phase 2